Logo image of ASA.OL

ATLANTIC SAPPHIRE ASA (ASA.OL) Stock Fundamental Analysis

OSL:ASA - Euronext Oslo - NO0013464750 - Common Stock - Currency: NOK

9.704  +0.2 (+2.13%)

Fundamental Rating

3

Overall ASA gets a fundamental rating of 3 out of 10. We evaluated ASA against 60 industry peers in the Food Products industry. The financial health of ASA is average, but there are quite some concerns on its profitability. ASA is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ASA had negative earnings in the past year.
ASA had a negative operating cash flow in the past year.
ASA had negative earnings in each of the past 5 years.
ASA had a negative operating cash flow in each of the past 5 years.
ASA.OL Yearly Net Income VS EBIT VS OCF VS FCFASA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

The Return On Assets of ASA (-61.14%) is worse than 93.33% of its industry peers.
With a Return On Equity value of -82.49%, ASA is not doing good in the industry: 88.33% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -61.14%
ROE -82.49%
ROIC N/A
ROA(3y)-39.47%
ROA(5y)-35.64%
ROE(3y)-50.56%
ROE(5y)-45.74%
ROIC(3y)N/A
ROIC(5y)N/A
ASA.OL Yearly ROA, ROE, ROICASA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ASA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASA.OL Yearly Profit, Operating, Gross MarginsASA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K

More info and screens

4

2. Health

2.1 Basic Checks

ASA does not have a ROIC to compare to the WACC, probably because it is not profitable.
ASA has more shares outstanding than it did 1 year ago.
ASA has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ASA has a worse debt to assets ratio.
ASA.OL Yearly Shares OutstandingASA.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ASA.OL Yearly Total Debt VS Total AssetsASA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ASA has an Altman-Z score of -3.58. This is a bad value and indicates that ASA is not financially healthy and even has some risk of bankruptcy.
ASA's Altman-Z score of -3.58 is on the low side compared to the rest of the industry. ASA is outperformed by 90.00% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that ASA is not too dependend on debt financing.
ASA's Debt to Equity ratio of 0.31 is amongst the best of the industry. ASA outperforms 81.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z -3.58
ROIC/WACCN/A
WACC8.4%
ASA.OL Yearly LT Debt VS Equity VS FCFASA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 7.60 indicates that ASA has no problem at all paying its short term obligations.
The Current ratio of ASA (7.60) is better than 98.33% of its industry peers.
A Quick Ratio of 6.83 indicates that ASA has no problem at all paying its short term obligations.
ASA has a better Quick ratio (6.83) than 98.33% of its industry peers.
Industry RankSector Rank
Current Ratio 7.6
Quick Ratio 6.83
ASA.OL Yearly Current Assets VS Current LiabilitesASA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.75% over the past year.
Looking at the last year, ASA shows a very strong growth in Revenue. The Revenue has grown by 63.05%.
Measured over the past years, ASA shows a very strong growth in Revenue. The Revenue has been growing by 32.73% on average per year.
EPS 1Y (TTM)76.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.07%
Revenue 1Y (TTM)63.05%
Revenue growth 3Y10.64%
Revenue growth 5Y32.73%
Sales Q2Q%95.77%

3.2 Future

ASA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 81.32% yearly.
The Revenue is expected to grow by 26.22% on average over the next years. This is a very strong growth
EPS Next Y116.3%
EPS Next 2Y81.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year70.85%
Revenue Next 2Y66.11%
Revenue Next 3Y11.1%
Revenue Next 5Y26.22%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ASA.OL Yearly Revenue VS EstimatesASA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
ASA.OL Yearly EPS VS EstimatesASA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -100 -200

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASA. In the last year negative earnings were reported.
ASA is valuated cheaply with a Price/Forward Earnings ratio of 0.32.
100.00% of the companies in the same industry are more expensive than ASA, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.36, ASA is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.32
ASA.OL Price Earnings VS Forward Price EarningsASA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASA.OL Per share dataASA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 -100 -150 -200

4.3 Compensation for Growth

ASA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ASA's earnings are expected to grow with 81.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y81.32%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ASA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATLANTIC SAPPHIRE ASA

OSL:ASA (8/6/2025, 4:02:45 PM)

9.704

+0.2 (+2.13%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-23 2025-04-23/amc
Earnings (Next)08-21 2025-08-21
Inst Owners10.16%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap347.89M
Analysts40
Price Target171.22 (1664.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-72.73%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.32
P/S 1.48
P/FCF N/A
P/OCF N/A
P/B 0.17
P/tB 0.17
EV/EBITDA N/A
EPS(TTM)-230.22
EYN/A
EPS(NY)30.21
Fwd EY311.33%
FCF(TTM)-27.64
FCFYN/A
OCF(TTM)-25.03
OCFYN/A
SpS6.54
BVpS58.1
TBVpS58.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -61.14%
ROE -82.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-39.47%
ROA(5y)-35.64%
ROE(3y)-50.56%
ROE(5y)-45.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 63.21%
Cap/Sales 39.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.6
Quick Ratio 6.83
Altman-Z -3.58
F-Score4
WACC8.4%
ROIC/WACCN/A
Cap/Depr(3y)200.58%
Cap/Depr(5y)377.87%
Cap/Sales(3y)159.27%
Cap/Sales(5y)358.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.07%
EPS Next Y116.3%
EPS Next 2Y81.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)63.05%
Revenue growth 3Y10.64%
Revenue growth 5Y32.73%
Sales Q2Q%95.77%
Revenue Next Year70.85%
Revenue Next 2Y66.11%
Revenue Next 3Y11.1%
Revenue Next 5Y26.22%
EBIT growth 1Y-21.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year203.68%
EBIT Next 3Y53.88%
EBIT Next 5Y49.12%
FCF growth 1Y0.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.35%
OCF growth 3YN/A
OCF growth 5YN/A